Already a member? Sign in
Category: Prescription Drugs
Ciprofloxacin is a fluoroquinolone antibiotic used for the short-term treatment of susceptible bacterial infections including urinary tract infections; lower respiratory tract infections; sinusitis; skin infections; bone and joint infections; infectious diarrhea.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| UTI symptoms | 42 | 13 |
|
|
|
||
| Other | 12 | 4 |
|
|
|||
| Prevent infection | 7 | 4 |
|
|
|||
| Diverticulitis | 7 | 3 |
|
||||
| Cystic Fibrosis | 4 | 2 |
|
|
|||
| Bladder problems | 4 | 1 |
|
See all 40 patients currently taking Ciprofloxacin
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Ciprofloxacin
| Diarrhea | 3 | |
|---|---|---|
| Oral thrush (candidiasis) | 2 | |
| Yeast Infection (candida) | 2 | |
| Allergic reaction | 1 | |
| Blood in urine (hematuria) | 1 | |
| Swollen lips | 1 | |
| See all 14 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Ciprofloxacin. See all 14 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Course of treatment ended | 82 | ||
| Doctor's advice | 10 | ||
| Side effects too severe | 5 | ||
| Did not seem to work | 2 | ||
| Other | 2 | ||
| Expense | 1 | ||
| Not indicated | 1 |
Adherence
Taking treatment as prescribed
Adherence of Ciprofloxacin
Always |
41 | 89% |
|
|---|---|---|---|
Usually |
5 | 11% |
|
Sometimes |
0 | 0% |
|
Never |
0 | 0% |
|
Burden
Difficulty being on treatment
Burden of Ciprofloxacin
Very |
0 | 0% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
10 | 22% |
|
Not at all |
36 | 78% |
|
Cost
Paid out of pocket
Cost of Ciprofloxacin
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
3 | 9% |
|
< $25 |
29 | 91% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 25, 2012.